Withdrawal from acute medication normalises short-term cortical synaptic potentiation in medication overuse headache
To study the effects of a standard acute medication withdrawal program on short-term cortical plasticity mechanisms in patients with medication overuse headache (MOH).
Thirteen patients with MOH and 16 healthy volunteers underwent repetitive transcranial magnetic stimulation (rTMS) over the left motor cortex; in patients with MOH, recordings were performed before and after a 3-week medication withdrawal program. Ten trains of 10 stimuli each (120% resting motor threshold) were delivered at 1 Hz or 5 Hz in two separate sessions in a randomised order. Motor evoked potential (MEP) amplitudes were measured from the right first dorsal interosseous muscle and the slope of the linear regression line from the first to the tenth stimuli was calculated for each participant.
All subjects exhibited MEP amplitude inhibition in response to 1 Hz rTMS. Alternatively, the 5-Hz trains of rTMS inhibited rather than potentiated MEP amplitudes in patients with MOH. The physiological potentiating effect of 5 Hz rTMS on MEP amplitudes was restored after drug withdrawal and in proportion with the percentage reduction in monthly headache days in patients with MOH.
The results suggest that acute medication withdrawal normalises brain responses in patients with MOH. Clinical improvements after medication withdrawal may reflect the reversal of neurophysiological dysfunction. Accordingly, medication withdrawal should be offered to patients with MOH as early as possible in order to prevent the development of more pronounced alterations in brain plasticity.
KeywordsChronic migraine Repetitive transcranial magnetic stimulation Short-term depression Short-term potentiation Synaptic plasticity
The contribution of the G.B. Bietti Foundation to this article was supported by the Italian Ministry of Health and Fondazione Roma.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.No authors listed (2018) Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211. https://doi.org/10.1177/0333102417738202
- 5.Rankin CH, Abrams T, Barry RJ, Bhatnagar S, Clayton DF, Colombo J, Coppola G, Geyer MA, Glanzman DL, Marsland S, McSweeney FK, Wilson DA, Wu CF, Thompson RF (2009) Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem 92:135–138. https://doi.org/10.1016/j.nlm.2008.09.012 CrossRefGoogle Scholar
- 6.Cortese F, Pierelli F, Pauri F, di Lorenzo C, Lepre C, Malavolta G, Merluzzo C, Parisi V, Serrao M, Coppola G (2018) Short-term cortical synaptic depression/potentiation mechanisms in chronic migraine patients with or without medication overuse. Cephalalgia 033310241878474. https://doi.org/10.1177/0333102418784747
- 14.Uddin LQ (2017) Anatomy of the salience network. In: Uddin LQ (ed) Salience Network of the Human Brain. Academic Press, Cambridge, pp 5–10Google Scholar
- 15.Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, Kaube H, Katsarava Z (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26:1106–1114. https://doi.org/10.1111/j.1468-2982.2006.01183.x CrossRefGoogle Scholar
- 21.Michels L, Christidi F, Steiger VR, Sándor PS, Gantenbein AR, Landmann G, Schreglmann SR, Kollias S, Riederer F (2017) Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain – a multimodal MRI study. Cephalalgia 37:764–779. https://doi.org/10.1177/0333102416652625 CrossRefGoogle Scholar